鹏华医药科技股票C(017900)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
1,367,518,106.71 |
1,168,845,936.69 |
-618,437,834.04 |
-794,518,939.35 |
| 利息合计 |
1,617,683.79 |
543,550.93 |
2,124,066.63 |
1,422,024.80 |
| 其中:存款利息收入 |
1,603,917.91 |
529,785.05 |
1,916,715.24 |
1,214,673.41 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
13,765.88 |
13,765.88 |
207,351.39 |
207,351.39 |
| 投资收益合计 |
1,103,020,238.29 |
443,438,554.74 |
-119,843,035.40 |
-206,131,484.98 |
| 其中:股票投资收益 |
1,094,962,526.06 |
439,610,052.56 |
-135,184,477.15 |
-211,838,149.09 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
8,057,712.23 |
3,828,502.18 |
15,341,441.75 |
5,706,664.11 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
244,801,714.42 |
717,527,178.11 |
-504,314,758.12 |
-591,567,186.10 |
| 其他收入 |
18,078,470.21 |
7,336,652.91 |
3,595,892.85 |
1,757,706.93 |
| 费用 |
47,642,383.50 |
19,945,783.13 |
50,452,046.79 |
28,024,417.17 |
| 管理人报酬 |
36,866,743.04 |
15,859,242.60 |
39,914,661.46 |
21,937,225.22 |
| 基金托管费 |
6,144,457.14 |
2,643,207.06 |
6,652,443.57 |
3,656,204.18 |
| 销售服务费 |
4,409,763.28 |
1,336,528.82 |
3,674,720.46 |
2,300,979.15 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
221,420.04 |
106,804.65 |
210,221.30 |
130,008.62 |
| 利润总额 |
1,319,875,723.21 |
1,148,900,153.56 |
-668,889,880.83 |
-822,543,356.52 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年